2019 Q2 Form 10-Q Financial Statement
#000162828019006102 Filed on May 07, 2019
Income Statement
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| Revenue | $26.15M | $21.81M | $18.03M |
| YoY Change | 37.56% | 20.99% | 92.58% |
| Cost Of Revenue | $9.022M | $8.640M | $7.666M |
| YoY Change | 16.71% | 12.71% | 7.84% |
| Gross Profit | $17.13M | $13.17M | $10.36M |
| YoY Change | 51.8% | 27.11% | 360.08% |
| Gross Profit Margin | 65.5% | 60.39% | 57.47% |
| Selling, General & Admin | $16.26M | $13.52M | $10.95M |
| YoY Change | 37.89% | 23.43% | 30.28% |
| % of Gross Profit | 94.92% | 102.66% | 105.72% |
| Research & Development | $21.07M | $3.008M | $3.729M |
| YoY Change | 463.52% | -19.33% | 7.56% |
| % of Gross Profit | 123.01% | 22.84% | 35.99% |
| Depreciation & Amortization | $400.0K | $324.0K | $427.0K |
| YoY Change | 5.26% | -24.12% | 4.4% |
| % of Gross Profit | 2.34% | 2.46% | 4.12% |
| Operating Expenses | $37.33M | $16.53M | $14.68M |
| YoY Change | 140.37% | 12.57% | 23.65% |
| Operating Profit | -$20.20M | -$3.358M | -$4.322M |
| YoY Change | 375.74% | -22.3% | -55.09% |
| Interest Expense | $2.000K | $2.000K | $432.0K |
| YoY Change | -99.55% | -99.54% | 64.89% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $408.0K | $514.0K | -$3.337M |
| YoY Change | -200.74% | -115.4% | 2052.9% |
| Pretax Income | -$19.79M | -$2.840M | -$7.660M |
| YoY Change | 325.59% | -62.92% | -21.68% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$19.79M | -$2.844M | -$7.659M |
| YoY Change | 325.54% | -62.87% | -21.67% |
| Net Earnings / Revenue | -75.68% | -13.04% | -42.49% |
| Basic Earnings Per Share | -$0.45 | -$0.07 | -$0.21 |
| Diluted Earnings Per Share | -$0.45 | -$0.07 | -$0.21 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 43.91M shares | 43.75M shares | 36.10M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $66.00M | $84.10M | $29.80M |
| YoY Change | -30.53% | 182.21% | 50.51% |
| Cash & Equivalents | $14.00M | $35.08M | $29.80M |
| Short-Term Investments | $52.00M | $49.00M | |
| Other Short-Term Assets | $2.167M | $2.679M | $1.358M |
| YoY Change | 63.3% | 97.28% | 33.4% |
| Inventory | $4.788M | $4.063M | $3.905M |
| Prepaid Expenses | |||
| Receivables | $21.08M | $18.77M | $13.16M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $94.05M | $109.6M | $48.20M |
| YoY Change | -19.97% | 127.38% | 30.45% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $6.963M | $6.445M | $4.207M |
| YoY Change | 49.0% | 53.2% | 15.64% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $31.78M | $31.63M | $4.207M |
| YoY Change | 580.03% | 651.79% | 15.64% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $94.05M | $109.6M | $48.20M |
| Total Long-Term Assets | $31.78M | $31.63M | $4.207M |
| Total Assets | $125.8M | $141.2M | $52.41M |
| YoY Change | 2.97% | 169.47% | 29.12% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $5.250M | $6.201M | $5.768M |
| YoY Change | 4.77% | 7.51% | -8.95% |
| Accrued Expenses | $7.300M | $6.600M | $678.0K |
| YoY Change | 43.14% | 873.45% | 12.07% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | $0.00 | $1.600M |
| YoY Change | -100.0% | -100.0% | 14.29% |
| Total Short-Term Liabilities | $12.54M | $12.94M | $13.88M |
| YoY Change | -17.59% | -6.75% | -5.92% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $100.0K | $100.0K | $15.65M |
| YoY Change | -99.31% | -99.36% | 80.31% |
| Other Long-Term Liabilities | $24.60M | $25.10M | $1.900M |
| YoY Change | 1130.0% | 1221.05% | 8947.62% |
| Total Long-Term Liabilities | $24.70M | $25.20M | $15.65M |
| YoY Change | 71.34% | 61.03% | 79.87% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $12.54M | $12.94M | $13.88M |
| Total Long-Term Liabilities | $24.70M | $25.20M | $15.65M |
| Total Liabilities | $37.28M | $38.17M | $31.47M |
| YoY Change | 18.01% | 21.29% | 25.47% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$391.7M | -$371.9M | -$368.5M |
| YoY Change | 4.96% | 0.9% | 4.29% |
| Common Stock | $480.1M | $474.8M | $389.1M |
| YoY Change | 3.57% | 22.03% | 5.53% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $88.54M | $103.1M | $20.94M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $125.8M | $141.2M | $52.41M |
| YoY Change | 2.97% | 169.47% | 29.12% |
Cashflow Statement
| Concept | 2019 Q2 | 2019 Q1 | 2018 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$19.79M | -$2.844M | -$7.659M |
| YoY Change | 325.54% | -62.87% | -21.67% |
| Depreciation, Depletion And Amortization | $400.0K | $324.0K | $427.0K |
| YoY Change | 5.26% | -24.12% | 4.4% |
| Cash From Operating Activities | -$18.38M | $154.0K | $405.0K |
| YoY Change | 237.25% | -61.98% | -112.97% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$990.0K | $232.0K | $184.0K |
| YoY Change | 23.75% | 26.09% | -362.86% |
| Acquisitions | $10.69M | $0.00 | |
| YoY Change | -100.0% | ||
| Other Investing Activities | -$2.810M | $15.89M | $0.00 |
| YoY Change | |||
| Cash From Investing Activities | -$3.810M | $15.66M | -$184.0K |
| YoY Change | 376.25% | -8611.96% | 162.86% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 1.070M | $982.0K | $2.694M |
| YoY Change | -98.5% | -63.55% | 4316.39% |
| NET CHANGE | |||
| Cash From Operating Activities | -18.38M | $154.0K | $405.0K |
| Cash From Investing Activities | -3.810M | $15.66M | -$184.0K |
| Cash From Financing Activities | 1.070M | $982.0K | $2.694M |
| Net Change In Cash | -21.12M | $16.80M | $2.915M |
| YoY Change | -132.4% | 476.26% | -193.1% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$18.38M | $154.0K | $405.0K |
| Capital Expenditures | -$990.0K | $232.0K | $184.0K |
| Free Cash Flow | -$17.39M | -$78.00K | $221.0K |
| YoY Change | 273.98% | -135.29% | -107.24% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q1 | astm |
Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
|
400000 | USD |
| CY2019Q1 | astm |
Depreciation Depletionand Amortization Excluding Intangible Assets
DepreciationDepletionandAmortizationExcludingIntangibleAssets
|
300000 | USD |
| CY2019Q1 | astm |
Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
|
0 | USD |
| CY2019Q1 | astm |
Finance Lease Liability Payments Dueafter Year Six
FinanceLeaseLiabilityPaymentsDueafterYearSix
|
0 | USD |
| CY2018Q1 | astm |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
0 | USD |
| CY2019Q1 | astm |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-310000 | USD |
| CY2019Q1 | astm |
Lease Liability
LeaseLiability
|
27651000 | USD |
| CY2019Q1 | astm |
Lease Liability
LeaseLiability
|
27800000 | USD |
| CY2019Q1 | astm |
Lease Liability Current
LeaseLiabilityCurrent
|
2418000 | USD |
| CY2019Q1 | astm |
Lease Liability Noncurrent
LeaseLiabilityNoncurrent
|
25233000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due
LeaseLiabilityPaymentsDue
|
39517000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due After Year Six
LeaseLiabilityPaymentsDueAfterYearSix
|
11269000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Remainder Of Fiscal Year
LeaseLiabilityPaymentsDueRemainderOfFiscalYear
|
3682000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Year Five
LeaseLiabilityPaymentsDueYearFive
|
4942000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Year Four
LeaseLiabilityPaymentsDueYearFour
|
4970000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Year Six
LeaseLiabilityPaymentsDueYearSix
|
4968000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Year Three
LeaseLiabilityPaymentsDueYearThree
|
4846000 | USD |
| CY2019Q1 | astm |
Lease Liability Payments Due Year Two
LeaseLiabilityPaymentsDueYearTwo
|
4840000 | USD |
| CY2019Q1 | astm |
Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
|
11866000 | USD |
| CY2019Q1 | astm |
Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
|
4968000 | USD |
| CY2019Q1 | astm |
Lessee Operating Lease Liability Payments Dueafter Year Six
LesseeOperatingLeaseLiabilityPaymentsDueafterYearSix
|
11269000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDue
|
15591000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Current
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueCurrent
|
4920000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Four Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInFourYears
|
1007000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Three Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInThreeYears
|
4795000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due In Two Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueInTwoYears
|
4760000 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Due Thereafter
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2018Q4 | astm |
Operatingand Capital Leasesand Purchase Commitments Future Minimum Payments Duein Five Years
OperatingandCapitalLeasesandPurchaseCommitmentsFutureMinimumPaymentsDueinFiveYears
|
109000 | USD |
| CY2019Q1 | astm |
Right Of Use Asset
RightOfUseAsset
|
25358000 | USD |
| CY2019Q1 | astm |
Right Of Use Asset
RightOfUseAsset
|
25600000 | USD |
| CY2018Q1 | astm |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
3728000 | USD |
| CY2018Q1 | astm |
Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
|
2000000 | USD |
| CY2019Q1 | astm |
Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
|
0 | USD |
| CY2019Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2019Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2019Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2019Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | |
| CY2019Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-03-31 | |
| CY2019Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2019Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000887359 | |
| CY2019Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
43911316 | shares |
| CY2019Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
| CY2019Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2019Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Vericel Corp | |
| CY2019Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2018Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6930000 | USD |
| CY2019Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4179000 | USD |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
7108000 | USD |
| CY2019Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6201000 | USD |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
23454000 | USD |
| CY2019Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
18774000 | USD |
| CY2018Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
0 | USD |
| CY2019Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
215000 | USD |
| CY2018Q4 | us-gaap |
Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
|
5161000 | USD |
| CY2019Q1 | us-gaap |
Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
|
798000 | USD |
| CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7505000 | USD |
| CY2019Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7829000 | USD |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-39000 | USD |
| CY2019Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
3000 | USD |
| CY2018Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1348000 | USD |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2628000 | USD |
| CY2018Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1342000 | USD |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2628000 | USD |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
514000 | USD |
| CY2019Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
669000 | USD |
| CY2018Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6200000 | shares |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6200000 | shares |
| CY2018Q4 | us-gaap |
Assets
Assets
|
118689000 | USD |
| CY2019Q1 | us-gaap |
Assets
Assets
|
141229000 | USD |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
112783000 | USD |
| CY2019Q1 | us-gaap |
Assets Current
AssetsCurrent
|
109601000 | USD |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
0 | USD |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
5000 | USD |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
39000 | USD |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
2000 | USD |
| CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
75515000 | USD |
| CY2019Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
75943000 | USD |
| CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
75476000 | USD |
| CY2019Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
75946000 | USD |
| CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
401000 | USD |
| CY2019Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
455000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
|
205000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
|
41000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
|
41000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
|
41000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
|
41000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
|
41000 | USD |
| CY2018Q4 | us-gaap |
Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2018Q1 | us-gaap |
Capital Leases Income Statement Interest Expense
CapitalLeasesIncomeStatementInterestExpense
|
1400000 | USD |
| CY2017Q4 | us-gaap |
Cash
Cash
|
26862000 | USD |
| CY2018Q1 | us-gaap |
Cash
Cash
|
29777000 | USD |
| CY2018Q4 | us-gaap |
Cash
Cash
|
18286000 | USD |
| CY2019Q1 | us-gaap |
Cash
Cash
|
35084000 | USD |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18286000 | USD |
| CY2019Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
35084000 | USD |
| CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2915000 | USD |
| CY2019Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
16798000 | USD |
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2019Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2019Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
43578000 | shares |
| CY2019Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
43825000 | shares |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
43578000 | shares |
| CY2019Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
43825000 | shares |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
471180000 | USD |
| CY2019Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
474806000 | USD |
| CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7659000 | USD |
| CY2019Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2802000 | USD |
| CY2019Q1 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
1900000 | USD |
| CY2018Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
1666000 | USD |
| CY2019Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
133000 | USD |
| CY2018Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
427000 | USD |
| CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
324000 | USD |
| CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
| CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1559000 | USD |
| CY2019Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2782000 | USD |
| CY2018Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2907000 | USD |
| CY2019Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2018Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
100000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
100000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
166000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
33000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
133000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
185000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
41000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
41000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
41000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
41000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
21000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
19000 | USD |
| CY2018Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
175000 | USD |
| CY2018Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
0 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
387000 | USD |
| CY2019Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.0500 | |
| CY2019Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y3M | |
| CY2018Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-44000 | USD |
| CY2019Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-6000 | USD |
| CY2018Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-22000 | USD |
| CY2019Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | USD |
| CY2018Q1 | us-gaap |
Gross Profit
GrossProfit
|
10361000 | USD |
| CY2019Q1 | us-gaap |
Gross Profit
GrossProfit
|
13170000 | USD |
| CY2019Q1 | us-gaap |
Incentive From Lessor
IncentiveFromLessor
|
2000000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-229000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1368000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1566000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-2751000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
112000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
505000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-223000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-168000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
102000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
46000 | USD |
| CY2018Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-5108000 | USD |
| CY2019Q1 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-4680000 | USD |
| CY2018Q1 | us-gaap |
Interest Expense
InterestExpense
|
432000 | USD |
| CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
2000 | USD |
| CY2018Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
357000 | USD |
| CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2000 | USD |
| CY2018Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
48000 | USD |
| CY2019Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
52000 | USD |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
3558000 | USD |
| CY2019Q1 | us-gaap |
Inventory Net
InventoryNet
|
4063000 | USD |
| CY2018Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2872000 | USD |
| CY2019Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3324000 | USD |
| CY2018Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
638000 | USD |
| CY2019Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
687000 | USD |
| CY2018Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD |
| CY2019Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
480000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
39332000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
4901000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
4929000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
4805000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4799000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3661000 | USD |
| CY2019Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
11847000 | USD |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
16458000 | USD |
| CY2019Q1 | us-gaap |
Liabilities
Liabilities
|
38174000 | USD |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
118689000 | USD |
| CY2019Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
141229000 | USD |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
14792000 | USD |
| CY2019Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12941000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2694000 | USD |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
982000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-184000 | USD |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
15662000 | USD |
| CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
405000 | USD |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
154000 | USD |
| CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7659000 | USD |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2844000 | USD |
| CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3337000 | USD |
| CY2019Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
514000 | USD |
| CY2019Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
| CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
14683000 | USD |
| CY2019Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
16528000 | USD |
| CY2018Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4322000 | USD |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3358000 | USD |
| CY2018Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1300000 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1300000 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
27485000 | USD |
| CY2018Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
0 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
2385000 | USD |
| CY2018Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
25100000 | USD |
| CY2018Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
25183000 | USD |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0956 | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P7Y6M15D | |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
15386000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
4879000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
68000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
966000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
4754000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
4719000 | USD |
| CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
| CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
210000 | USD |
| CY2019Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
599000 | USD |
| CY2018Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2847000 | USD |
| CY2019Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2679000 | USD |
| CY2018Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
0 | USD |
| CY2019Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
42000 | USD |
| CY2018Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
754000 | USD |
| CY2019Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
176000 | USD |
| CY2018Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
| CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
36000 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | USD |
| CY2019Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
10686000 | USD |
| CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
184000 | USD |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
232000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-18000 | USD |
| CY2019Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-16000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
0 | USD |
| CY2019Q1 | us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
26580000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
985000 | USD |
| CY2019Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
998000 | USD |
| CY2018Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1727000 | USD |
| CY2019Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
13411000 | USD |
| CY2019Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
14274000 | USD |
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5906000 | USD |
| CY2019Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6445000 | USD |
| CY2018Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3729000 | USD |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3008000 | USD |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-369014000 | USD |
| CY2019Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-371858000 | USD |
| CY2018Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18027000 | USD |
| CY2019Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
22000 | USD |
| CY2018Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | USD |
| CY2019Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
185000 | USD |
| CY2018Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
10954000 | USD |
| CY2019Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
13520000 | USD |
| CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1342000 | USD |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2628000 | USD |
| CY2018Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
64638000 | USD |
| CY2019Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
49001000 | USD |
| CY2019Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
100000 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
127000 | USD |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
218000 | USD |
| CY2018Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
851000 | USD |
| CY2019Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
780000 | USD |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22540000 | USD |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20935000 | USD |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
102231000 | USD |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
103055000 | USD |
| CY2019Q1 | us-gaap |
Unrealized Loss On Securities
UnrealizedLossOnSecurities
|
-42000 | USD |
| CY2018Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
104000 | USD |
| CY2019Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
104000 | USD |
| CY2018Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36140000 | shares |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
43725000 | shares |
| CY2019Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements included herein have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC).  The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (U.S. GAAP) requires management to make estimates, judgments, and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. The financial statements reflect, in the opinion of management, all adjustments (consisting only of normal, recurring adjustments) necessary to state fairly the financial position and results of operations as of and for the periods indicated.  The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, are not necessarily indicative of the results to be expected for the full year or for any other period. The </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> condensed consolidated balance sheet data was derived from the Company’s audited consolidated financial statements, but does not include all disclosures required by U.S. GAAP.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, as filed with the SEC on February 26, 2019 (Annual Report).</font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Consolidated Statement of Cash Flows</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents certain supplementary cash flows information for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Supplementary Cash Flows information:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants exercised for common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest paid (net of interest capitalized)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions to equipment in process included in accounts payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use asset recognized</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> | |
| CY2019Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vericel Corporation, a Michigan corporation (together with its consolidated subsidiaries referred to herein as the Company, Vericel, we, us or our), was incorporated in March 1989 and began employee-based operations in 1991. On May 30, 2014, Vericel completed the acquisition of certain assets and assumed certain liabilities of Sanofi, a French </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">société anonyme</font><font style="font-family:inherit;font-size:10pt;"> (Sanofi), including all of the outstanding equity interests of Genzyme Biosurgery ApS (Genzyme Denmark or the Danish subsidiary) (now known as Vericel Denmark ApS), a wholly-owned subsidiary of Sanofi, and a portfolio of patents and patent applications of Sanofi and certain of its subsidiaries for purposes of acquiring the portion of the cell therapy and regenerative medicine business related to the MACI</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, Epicel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and Carticel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> products. The Company is a fully integrated, commercial-stage biopharmaceutical company and currently markets MACI and Epicel in the U.S. The Company is a leader in advanced cell therapies for the sports medicine and severe burn care markets. </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. At the end of the second quarter of 2017, the Company removed Carticel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(autologous cultured chondrocytes), an earlier generation autologous chrondocyte implant (ACI) product, from the market. The Company also markets Epicel</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(cultured epidermal autografts), a permanent skin replacement Humanitarian Use Device (HUD) for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area (TBSA). The Company operates its business primarily in the U.S. in </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reportable segment — the research, product development, manufacture and distribution of advanced cellular therapies for use in the treatment of specific diseases.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#222222;">The accompanying condensed consolidated financial statements have been prepared on a basis, which assumes that the Company will continue as a going concern and contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business.  As of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#222222;">, the Company has an accumulated deficit of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">$371.9 million</font><font style="font-family:inherit;font-size:10pt;color:#222222;"> and had a net loss of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;color:#222222;"> during the quarter ended </font><font style="font-family:inherit;font-size:10pt;color:#222222;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#222222;">.  The Company had cash and cash equivalents of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">$35.1 million</font><font style="font-family:inherit;font-size:10pt;color:#222222;">, and short term investments of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">$49.0 million</font><font style="font-family:inherit;font-size:10pt;color:#222222;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#222222;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#222222;">.  The Company expects that existing cash, cash equivalents and short term investments will be sufficient to support the Company's </font><font style="font-family:inherit;font-size:10pt;">current operations through at least May 2020.</font><font style="font-family:inherit;font-size:10pt;color:#222222;"> The Company may seek additional funding through debt or equity financings.  However, the Company may not be able to obtain financing on acceptable terms or at all. The terms of any financing may adversely affect the holdings or the rights of the Company's shareholders.</font></div></div> |
